Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women

Mirette Hanna, Isabelle Dumas, Michèle Orain, Simon Jacob, Bernard Têtu, François Sanschagrin, Alexandre Bureau, Brigitte Poirier, Caroline Diorio

Research output: Contribution to journalArticle

Abstract

Objective: Inflammatory markers may be associated with breast cancer risk. We assessed the association between expression levels of proinflammatory (interleukin 6, tumor necrosis factor-α, C-reactive protein, cyclo-oxygenase 2, leptin, serum amyloid A1, interleukin 8, and signal transducer and activator of transcription 3) and anti-inflammatory markers (transforming growth factor-β, interleukin 10, and lactoferrin) in normal breast tissue with mammographic density, a strong breast cancer risk indicator, among 163 breast cancer patients. Methods: The expression of inflammatory markers was visually evaluated on immunohistochemistry stained slides. The percent mammographic density (PMD) was estimated by a computer-assisted method in the contralateral cancer-free breast. We used generalized linear models to estimate means of PMD by median expression levels of the inflammatory markers while adjusting for age and waist circumference. Results: Higher expression levels (above median) of the proinflammatory marker interleukin 6 were associated with higher PMD among all women (24.1% vs 18.5%, P = 0.007). Similarly, higher expression levels (above median) of the proinflammatory markers (interleukin 6, tumor necrosis factor-a, C-reactive protein, and interleukin 8) were associated with higher PMD among premenopausal women (absolute difference in the PMD of 8.8% [P= 0.006], 7.7% [P = 0.022], 6.7% [P = 0.037], and 16.5% [P = 0.032], respectively). Higher expression levels (above median) of the anti-inflammatory marker transforming growth factor-b were associated with lower PMD among all (18.8% vs 24.3%, P=0.005) and postmenopausal women (14.5% vs 20.7%, P=0.013). Conclusions: Our results provide support for the hypothesized role of inflammatory markers in breast carcinogenesis through their effects on mammographic density. Inflammatory markers could be targeted in future breast cancer prevention interventions.

Original languageEnglish (US)
Pages (from-to)524-535
Number of pages12
JournalMenopause
Volume24
Issue number5
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Breast Neoplasms
Lymphotoxin-beta
Interleukin-6
Transforming Growth Factors
Interleukin-8
C-Reactive Protein
Breast
Anti-Inflammatory Agents
STAT3 Transcription Factor
Lactoferrin
Breast Density
Waist Circumference
Prostaglandin-Endoperoxide Synthases
Leptin
Amyloid
Interleukin-10
Linear Models
Carcinogenesis
Immunohistochemistry
Serum

Keywords

  • Breast cancer risk
  • Inflammatory markers
  • Mammographic density

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women. / Hanna, Mirette; Dumas, Isabelle; Orain, Michèle; Jacob, Simon; Têtu, Bernard; Sanschagrin, François; Bureau, Alexandre; Poirier, Brigitte; Diorio, Caroline.

In: Menopause, Vol. 24, No. 5, 01.01.2017, p. 524-535.

Research output: Contribution to journalArticle

Hanna, Mirette ; Dumas, Isabelle ; Orain, Michèle ; Jacob, Simon ; Têtu, Bernard ; Sanschagrin, François ; Bureau, Alexandre ; Poirier, Brigitte ; Diorio, Caroline. / Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women. In: Menopause. 2017 ; Vol. 24, No. 5. pp. 524-535.
@article{5637f4c621984693a2aed53fd9c7fe20,
title = "Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women",
abstract = "Objective: Inflammatory markers may be associated with breast cancer risk. We assessed the association between expression levels of proinflammatory (interleukin 6, tumor necrosis factor-α, C-reactive protein, cyclo-oxygenase 2, leptin, serum amyloid A1, interleukin 8, and signal transducer and activator of transcription 3) and anti-inflammatory markers (transforming growth factor-β, interleukin 10, and lactoferrin) in normal breast tissue with mammographic density, a strong breast cancer risk indicator, among 163 breast cancer patients. Methods: The expression of inflammatory markers was visually evaluated on immunohistochemistry stained slides. The percent mammographic density (PMD) was estimated by a computer-assisted method in the contralateral cancer-free breast. We used generalized linear models to estimate means of PMD by median expression levels of the inflammatory markers while adjusting for age and waist circumference. Results: Higher expression levels (above median) of the proinflammatory marker interleukin 6 were associated with higher PMD among all women (24.1{\%} vs 18.5{\%}, P = 0.007). Similarly, higher expression levels (above median) of the proinflammatory markers (interleukin 6, tumor necrosis factor-a, C-reactive protein, and interleukin 8) were associated with higher PMD among premenopausal women (absolute difference in the PMD of 8.8{\%} [P= 0.006], 7.7{\%} [P = 0.022], 6.7{\%} [P = 0.037], and 16.5{\%} [P = 0.032], respectively). Higher expression levels (above median) of the anti-inflammatory marker transforming growth factor-b were associated with lower PMD among all (18.8{\%} vs 24.3{\%}, P=0.005) and postmenopausal women (14.5{\%} vs 20.7{\%}, P=0.013). Conclusions: Our results provide support for the hypothesized role of inflammatory markers in breast carcinogenesis through their effects on mammographic density. Inflammatory markers could be targeted in future breast cancer prevention interventions.",
keywords = "Breast cancer risk, Inflammatory markers, Mammographic density",
author = "Mirette Hanna and Isabelle Dumas and Mich{\`e}le Orain and Simon Jacob and Bernard T{\^e}tu and Fran{\cc}ois Sanschagrin and Alexandre Bureau and Brigitte Poirier and Caroline Diorio",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/GME.0000000000000794",
language = "English (US)",
volume = "24",
pages = "524--535",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women

AU - Hanna, Mirette

AU - Dumas, Isabelle

AU - Orain, Michèle

AU - Jacob, Simon

AU - Têtu, Bernard

AU - Sanschagrin, François

AU - Bureau, Alexandre

AU - Poirier, Brigitte

AU - Diorio, Caroline

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective: Inflammatory markers may be associated with breast cancer risk. We assessed the association between expression levels of proinflammatory (interleukin 6, tumor necrosis factor-α, C-reactive protein, cyclo-oxygenase 2, leptin, serum amyloid A1, interleukin 8, and signal transducer and activator of transcription 3) and anti-inflammatory markers (transforming growth factor-β, interleukin 10, and lactoferrin) in normal breast tissue with mammographic density, a strong breast cancer risk indicator, among 163 breast cancer patients. Methods: The expression of inflammatory markers was visually evaluated on immunohistochemistry stained slides. The percent mammographic density (PMD) was estimated by a computer-assisted method in the contralateral cancer-free breast. We used generalized linear models to estimate means of PMD by median expression levels of the inflammatory markers while adjusting for age and waist circumference. Results: Higher expression levels (above median) of the proinflammatory marker interleukin 6 were associated with higher PMD among all women (24.1% vs 18.5%, P = 0.007). Similarly, higher expression levels (above median) of the proinflammatory markers (interleukin 6, tumor necrosis factor-a, C-reactive protein, and interleukin 8) were associated with higher PMD among premenopausal women (absolute difference in the PMD of 8.8% [P= 0.006], 7.7% [P = 0.022], 6.7% [P = 0.037], and 16.5% [P = 0.032], respectively). Higher expression levels (above median) of the anti-inflammatory marker transforming growth factor-b were associated with lower PMD among all (18.8% vs 24.3%, P=0.005) and postmenopausal women (14.5% vs 20.7%, P=0.013). Conclusions: Our results provide support for the hypothesized role of inflammatory markers in breast carcinogenesis through their effects on mammographic density. Inflammatory markers could be targeted in future breast cancer prevention interventions.

AB - Objective: Inflammatory markers may be associated with breast cancer risk. We assessed the association between expression levels of proinflammatory (interleukin 6, tumor necrosis factor-α, C-reactive protein, cyclo-oxygenase 2, leptin, serum amyloid A1, interleukin 8, and signal transducer and activator of transcription 3) and anti-inflammatory markers (transforming growth factor-β, interleukin 10, and lactoferrin) in normal breast tissue with mammographic density, a strong breast cancer risk indicator, among 163 breast cancer patients. Methods: The expression of inflammatory markers was visually evaluated on immunohistochemistry stained slides. The percent mammographic density (PMD) was estimated by a computer-assisted method in the contralateral cancer-free breast. We used generalized linear models to estimate means of PMD by median expression levels of the inflammatory markers while adjusting for age and waist circumference. Results: Higher expression levels (above median) of the proinflammatory marker interleukin 6 were associated with higher PMD among all women (24.1% vs 18.5%, P = 0.007). Similarly, higher expression levels (above median) of the proinflammatory markers (interleukin 6, tumor necrosis factor-a, C-reactive protein, and interleukin 8) were associated with higher PMD among premenopausal women (absolute difference in the PMD of 8.8% [P= 0.006], 7.7% [P = 0.022], 6.7% [P = 0.037], and 16.5% [P = 0.032], respectively). Higher expression levels (above median) of the anti-inflammatory marker transforming growth factor-b were associated with lower PMD among all (18.8% vs 24.3%, P=0.005) and postmenopausal women (14.5% vs 20.7%, P=0.013). Conclusions: Our results provide support for the hypothesized role of inflammatory markers in breast carcinogenesis through their effects on mammographic density. Inflammatory markers could be targeted in future breast cancer prevention interventions.

KW - Breast cancer risk

KW - Inflammatory markers

KW - Mammographic density

UR - http://www.scopus.com/inward/record.url?scp=85007240649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007240649&partnerID=8YFLogxK

U2 - 10.1097/GME.0000000000000794

DO - 10.1097/GME.0000000000000794

M3 - Article

C2 - 28002200

AN - SCOPUS:85007240649

VL - 24

SP - 524

EP - 535

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 5

ER -